| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000014719 |
| Receipt No. | R000017109 |
| Official scientific title of the study | Efficacy and safety of corneal crosslinking using KXL for keratoconic eyes |
| Date of disclosure of the study information | 2014/08/01 |
| Last modified on | 2018/02/01 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Efficacy and safety of corneal crosslinking using KXL for keratoconic eyes | |
| Title of the study (Brief title) | Corneal crosslinking using KXL | |
| Region |
|
|
| Condition | ||
| Condition | Keratoconus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess efficacy and safety of corneal crosslinking using a new protocol (ultraviolet irradiation; 18 mW/cm2 x 5 minutes) with the KXL(R)(Avedro, Inc) for progressing keratoconic eyes. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change of visual acuity, manifest refraction, keratometric value, and corneal topography |
| Key secondary outcomes | Decrease of best corrected visual acuity, decrease of endothelial cell counts, and frequency of complications |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Corneal crosslinking | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those who reveal all of following factors;
1. Keratoconus or keartectasia pattern by corneal topography/tomography 2. Thinnest corneal thickness is 400 um or more. 3. Progression of keratoconus in recent 2 years by corneal topography/tomography and/or manifest refraction. Progression of keratectasia after corneal refractive surgery. 4. Age 40 year-old or more. |
|||
| Key exclusion criteria | Those who reveal one or more of following factors;
1. Thinnest corneal thickness is less than 400 um. 2. Corneal stromal opacity 3. Those who implanted artificial cardiac pacemaker or similar devices. 4. Ocular diseases, such as scar, herpetic infection, or nystagmus. 5. Infectious corneal disorders with unkonwn causes. 6. General diseases that can affect the corneal wound healing 7. Nallow angle, pregnancy, breast feeding 8. Occupation that is not allowed performing corneal refractive surgeries 9. Age less than 14 year-old |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Jun Shimazaki |
| Organization | Ichikawa General Hospital, Tokyo Dental College |
| Division name | Department of Ophthalmology |
| Address | 5-11-13 Sugano, Ichikawa, Chiba, Japan |
| TEL | 047-322-0151 |
| jun@eyebank.or.jp | |
| Public contact | |
| Name of contact person | Jun Shimazaki |
| Organization | Ichikawa General Hospital, Tokyo Dental College |
| Division name | Department of Ophthalmology |
| Address | 5-11-13 Sugano, Ichikawa, Chiba, Japan |
| TEL | 047-322-0151 |
| Homepage URL | |
| jun@eyebank.or.jp | |
| Sponsor | |
| Institute | Department of Ophthalmology, Ichikawa General Hospital, Tokyo Dental College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokyo Dental College |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017109 |